We also found that the induction of colitis and treatment with a DOR agonist did not affect the expression levels of opioid receptors or endogenous opioids in the CNS, which may support the noninvolvement of the CNS in the effect of KNT-127 on the colitis. This evidence concerns the gene OPRD1 and colitis.